Last reviewed · How we verify
NCT07410260
Extracorporeal Shock Wave Therapy for Shoulder Impingement
NA trial testing Conventional treatment programme in Extracorporeal Shock Wave Therapy in 30 participants. Completed in 20 December 2019.
20 November 2019
Quick facts
| Lead sponsor | Istinye University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 January 2019 |
| Primary completion | 20 November 2019 |
| Estimated completion | 20 December 2019 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Conventional treatment programme
- Exercise programme
- Extracorporeal Shock Wave Therapy
Conditions studied
- Extracorporeal Shock Wave Therapy — all drugs for Extracorporeal Shock Wave Therapy →
- Shoulder Impingement Syndrome — all drugs for Shoulder Impingement Syndrome →
Sponsor
Istinye University
Who can join
Adults 18 to 65, any sex, with Extracorporeal Shock Wave Therapy or Shoulder Impingement Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The aim of this study was to investigate the effects of extracorporeal shock wave therapy (ESWT) on pain, upper extremity functional level and sleep quality in subacromial impingement syndrome. Methods: Thirty patients diagnosed with impingement syndrome were randomly divided into two groups. ESWT group, ESWT was applied one day a week in addition to a conventional physiotherapy programme consisting of ultrasound, transcutaneous electrical nerve stimulation (TENS), infrared and exercise 5 days a week for three weeks. Control group received only conventional physiotherapy programme. Constant Murley Shoulder Score (CMS), The University of California-Los Angeles (UCLA) shoulder scale, Shoulder Pain and Disability Index (SPADI), Short Form Mc-Gill Pain Questionnaire (SF-MPQ ), VAS and Pittsburgh Sleep Quality Index (PSQI) were used in the evaluation. Joint range of motion was assessed using a universal goniometer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07410260
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Extracorporeal Shock Wave Therapy
Currently open trials in the same condition.
- NCT06491745 — Is Adding Extracorporeal Shock Wave Therapy to Physiotherapy and Corticosteroid Injection Beneficial for Frozen Shoulder · NA · recruiting
- NCT06438224 — Clinical Utility of ESWT in Restoring Hand Function of Patients With Nerve Injury and Hypertrophic Scars Due to Burns · NA · recruiting
Other Istinye University trials
Trials by the same sponsor.
- NCT06963294 — Ketamine and Dexmedetomidine for Delirium in Joint Arthroplasty · NA · not yet recruiting
- NCT07528807 — Exercise, Pain Beliefs, and Activity Patterns in Musculoskeletal Pain · not yet recruiting
- NCT07520981 — Functional Capacity, Subjective Dyspnea and Fatigue in Smokers · not yet recruiting
- NCT07518095 — Serum Bicarbonate and Enteral Feeding Intolerance in Adult ICU: A Prospective Clinical Trial · not yet recruiting
- NCT07483190 — Effectiveness of Thoracoabdominal Nerve Block (M-TAPA) on Postoperative Pain Relief in Laparoscopic Hysterectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07410260 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istinye University
- Last refreshed: 13 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07410260.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing